This selection from the NCCN Guidelines for Rectal Cancer focuses on management of
malignant polyps and resectable nonmetastatic rectal cancer because important updates …

The American Society of Colon and Rectal Surgeons (ASCRS) is dedicated to ensuring high-
quality patient care by advancing the science, prevention, and management of disorders …

Because of recent advances in medical technology and new findings of clinical trials,
treatment options for colorectal cancer are evolutionally changing, even in the last few years …

Background Treatment of locally advanced rectal cancer with chemoradiotherapy, surgery,
and adjuvant chemotherapy controls local disease, but distant metastases remain common …

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Rectal Cancer
address diagnosis, staging, surgical management, perioperative treatment, management of …

The introduction of checkpoint inhibitors provided remarkable achievements in several solid
tumors but only 5% of metastatic colorectal cancer (mCRC) patients, ie, those with bearing …

PURPOSE In the multicenter, open-label, phase III FOWARC trial, modified infusional
fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6) plus radiotherapy resulted in a higher …

Background Deep learning (DL) models can potentially improve prognostication of rectal
cancer but have not been systematically assessed. Purpose To develop and validate an MRI …

Importance Treatment of locally advanced rectal cancer (LARC) involves neoadjuvant
chemoradiotherapy plus total mesorectal excision and adjuvant chemotherapy. However …

Locally advanced rectal cancer has a rising global incidence. Over the last 4 decades,
advances first in surgery and later in radiotherapy and chemoradiotherapy have improved …